News

Health experts warn against self-testing for Covid-19

Maitri Porecha New Delhi | Updated on April 05, 2020 Published on April 05, 2020

Health experts have warned against ordering rapid antibody diagnostic testing kits online for self-testing for novel coronavirus (Covid-19) as the results may not be accurate.

Lav Agarwal, Joint Secretary, Ministry of Health and Family Welfare, has clarified that the tests can be done only in authorised health facilities.

 

Home screening kit

All India Drug Action Network (AIDAN) has written to the Central government to examine a Bengaluru-based private company Bione offering a “simple point-of-care home screening kit” directly to consumers through its website.

“These kits are available for screening online at between ₹2,000 and ₹3000. We have already sold out our first batch, and we are asking people to buy two of them, and retest themselves after seven days in case the first time around the result is negative,” said Ruchi Dana, founding investor.

Read also: ICMR approves TB machines for Covid-19 testing

 

ICMR unaware

Raman Gangakhedar, head, infectious diseases in ICMR, told Businessline, “I am not aware of such a company selling kits online. ICMR will look into the matter and will convey appropriate steps after discussing it.”

While Indian Council of Medical Research has allowed use of antibody kits which are either validated domestically or have been approved by European regulator CE-IVD for use by States for community screening, it has yet not released any guidance on whether individuals can be self-tested at home.

While Bione claims that it has received all regulatory approvals, its name is missing from ICMR’s list of kits that can be used for rapid screening. To this, Dana said, “Bione is importing kits from the ICMR approved vendors, but we cannot share their names.”

While ICMR has put out a list of all antibody kit suppliers, Drug Controller General of India has not made public the list of the suppliers allowed to conduct business in India. “In the absence of a public list of all Covid-19 test kits approved by DCGI, it is impossible for us to verify such claims,” said Malini Aisola, co-convenor, AIDAN.

Suresh Vazirani, founder chairman of Transasia, a leading medical equipment supplier to labs, warned against self- testing. “Accuracy of such kits is hardly 70 per cent. In 30 per cent of cases, you may get a false positive which may lead to worries. If you get a false negative result, the patient may miss the government scanner. In the absence of guidelines, selling kits online may be a violation of ICMR testing strategy,” he said.

Unknown provenance

“No details are available on the company website regarding the foreign manufacturers of the kits, approvals in India, or the test kit's performance. The kit is being sold online without the need for a physician's prescription. It is impossible to determine the efficacy of the test kit, which resembles a pregnancy test in appearance,” said Chinu Srinivasan, founder of Low Cost Standard Therapeutics and an expert on pharma policy.

Bione is also selling two more products for Covid-19 – a microbiome kit which claims to test faeces to check a person’s predisposition to the virus priced at ₹14,999, and a genetic susceptibility kit at ₹7,999 online. “We would like to know whether CDSCO has approved any of these kits being marketed by Bione,” Srinivasan said.

Read more: Cruise ship Karnika to serve as a floating quarantine facility

 

 

 

Published on April 05, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.